Contents
Download PDF
pdf Download XML
943 Views
131 Downloads
Share this article
Research Article | Volume 13 Issue:1 (, 2023) | Pages 100 - 106
Outcome of Injection Sclerotherapy Using Absolute Alcohol in Patients with Esophageal Varices
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
Jan. 20, 2023
Abstract

Introduction:Lower end of the esophagus portosystemic anastomosis formed by Left gastric vein and Esophageal tributaries of accessory hemizygous vein. Although all these vessels contribute to the shunting of esophageal collaterals or varices, are the most important clinically, because of their predilection to bleeding. Sclerotherapy is associated with a wide range of complications ranging from transient pyrexia to esophageal perforation resulting in death. Complications following sclerotherapy depends on a number of factors namely nature of sclerosant used, amount of sclerosant, injection site, concentration of the drug and the time interval between the sessions. Material And Methods: A prospective and observation study on management of esophageal varices by endoscopic injection sclerotherapy using absolute alcohol as sclerosant has been done in Endoscopy Unit.

Keywords
Recommended Articles
Original Article
Clinical Profile and Predictors of Severe Dengue in Adult Patients at a Tertiary Care Teaching Hospital: A Hospital-Based Observational Study
Published: 28/03/2023
Download PDF
Research Article
A Study of Vitamin D Status in Patients with Type 2 Diabetes Mellitus and Its Association with Glycemic Control
Published: 30/05/2023
Download PDF
Research Article
High Prevalence of Accessory Pathway-Mediated Paroxysmal Supraventricular Tachycardia in the Hill Population of Sikkim and Favorable Outcomes Following 2D Electrophysiological Study and Radiofrequency Ablation
...
Published: 27/10/2026
Download PDF
Research Article
Thrombocytopenia: An independent poor prognostic marker in Traumatic Brain Injury patients
...
Published: 28/12/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.